PI 3-kinase/Akt and STAT3 are required for the prevention of TGF-β-induced Hep3B cell apoptosis by autocrine motility factor/phosphoglucose isomerase

Cancer Letters

Volumn 290, Issue 2, 2010, Pages 223-237

  Shih, Wen Ling ^a   Liao, Ming Huei ^a   Lin, Ping Yuan ^b   Chang, Chi I ^a   Cheng, Hsueh Ling ^a   Yu, Feng Ling ^c   Lee, Jeng Woei ^b  

^a NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c TZU HUI INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

Akt; AMF PGI; PI 3 kinase; STAT3; TGF

Indexed keywords

AUTOCRINE MOTILITY FACTOR; GLUCOSE 6 PHOSPHATE ISOMERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN KINASE B; PROTEIN P110; SMAD3 PROTEIN; SMAD4 PROTEIN; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; AUTOCRINE MOTILITY FACTOR; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SEPARATION; FLOW CYTOMETRY; GENE EXPRESSION; GLUCOSE-6-PHOSPHATE ISOMERASE; HUMANS; IMMUNOPRECIPITATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 77649179124     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.09.014     Document Type: Article

References (60)

1. Michalopoulos G.K., and DeFrances M.C. Liver regeneration. Science 276 (1997) 60-66
2. Lin J.K., and Chou C.K. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor beta 1. Cancer Res. 52 (1992) 385-388
3. Fukuda K., Kojiro M., and Chiu J.F. Differential regulation of tissue transglutaminase in rat hepatoma cell lines McA-RH7777 and McA-RH8994: relation to growth rate and cell death. J. Cell. Biochem. 54 (1994) 67-77
4. Fan G., Ma X., Kren B.T., and Steer C.J. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Oncogene 12 (1996) 1909-1919
5. Derynck R., and Feng X.H. TGF-beta receptor signaling. Biochim. Biophys. Acta 1333 (1997) F105-F150
6. Piek E., Franzen P., Heldin C.H., and ten Dijke P. Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding. J. Cell. Physiol. 173 (1997) 447-459
7. Zhang Y., and Derynck R. Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol. 9 (1999) 274-279
8. Chen R.H., and Chang T.Y. Involvement of caspase family proteases in transforming growth factor-beta-induced apoptosis. Cell Growth Differ. 8 (1997) 821-827
9. Jang C.W., Chen C.H., Chen C.C., Chen J.Y., Su Y.H., and Chen R.H. TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase. Nat. Cell. Biol. 4 (2002) 51-58
10. Tanaka S., and Wands J.R. Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis. Cancer Res. 56 (1996) 3391-3394
11. Chen R.H., Chang M.C., Su Y.H., Tsai Y.T., and Kuo M.L. Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J. Biol. Chem. 274 (1999) 23013-23019
12. Zha J., Harada H., Yang E., Jockel J., and Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87 (1996) 619-628
13. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., Frisch S., and Reed J.C. Regulation of cell death protease caspase-9 by phosphorylation. Science 282 (1998) 1318-1321
14. Kennedy S.G., Kandel E.S., Cross T.K., and Hay N. Akt/protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol. Cell. Biol. 19 (1999) 5800-5810
15. Shih W.L., Kuo M.L., Chuang S.E., Cheng A.L., and Doong S.L. Hepatitis B virus X protein inhibits transforming growth factor-beta-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 275 (2000) 25858-25864
16. Rose I.A., and O'Connell E.L. Intramolecular hydrogen transfer in the phosphoglucose isomerase reaction. J. Biol. Chem. 236 (1961) 3086-3092
17. Schray K.J., Benkovic S.J., Benkovic P.A., and Rose I.A. Catalytic reactions of phosphoglucose isomerase with cyclic forms of glucose 6-phosphate and fructose 6-phosphate. J. Biol. Chem. 248 (1973) 2219-2224
18. Welch S.G. Qualitative and quantitative variants of human phosphoglucose isomerase. Hum. Hered. 21 (1971) 467-477
19. Beutler E., West C., Britton H.A., Harris J., and Forman L. Glucosephosphate isomerase (GPI) deficiency mutations associated with hereditary nonspherocytic hemolytic anemia (HNSHA). Blood Cells Mol. Dis. 23 (1997) 402-409
20. Huppke P., Wunsch D., Pekrun A., Kind R., Winkler H., Schroter W., and Lakomek M. Glucose phosphate isomerase deficiency: biochemical and molecular genetic studies on the enzyme variants of two patients with severe haemolytic anaemia. Eur. J. Pediatr. 156 (1997) 605-609
21. Baumann M., Kappl A., Lang T., Brand K., Siegfried W., and Paterok E. The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer. Cancer Invest. 8 (1990) 351-356
22. Watanabe H., Carmi P., Hogan V., Raz T., Silletti S., Nabi I.R., and Raz I.R.A. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J. Biol. Chem. 266 (1991) 13442-13448
23. Torimura T., Ueno T., Kin M., Harada R., Nakamura T., Kawaguchi T., Harada M., Kumashiro R., Watanabe H., Avraham R., and Sata M. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins. Hepatology 34 (2001) 62-71
24. Yu F.L., Liao M.H., Lee J.W., and Shih W.L. Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3. Biochem. Biophys. Res. Commun. 314 (2004) 76-82
25. Tsutsumi S., Hogan V., Nabi I.R., and Raz A. Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts. Cancer Res. 63 (2003) 242-249
26. Tsutsumi S., Yanagawa T., Shimura T., Fukumori T., Hogan V., Kuwano H., and Raz A. Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling. J. Biol. Chem. 278 (2003) 32165-32172
27. Haga A., Funasaka T., Niinaka Y., Raz A., and Nagase H. Autocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf-1 and Caspase-9 apoptosome expression. Int. J. Cancer 107 (2003) 707-714
28. Shih W.L., Liao M.H., Yu F.L., Lin P.Y., Hsu H.Y., and Chiu S.J. AMF/PGI transactivates the MMP-3 gene through the activation of Src-RhoA-phosphatidylinositol 3-kinase signaling to induce hepatoma cell migration. Cancer Lett. 270 (2008) 202-217
29. Feng X.H., Filvaroff E.H., and Derynck R. Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors. J. Biol. Chem. 270 (1995) 24237-24245
30. Hu Q., Klippel A., Muslin A.J., Fantl W.J., and Williams L.T. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science 268 (1995) 100-102
31. Kulik G., Klippel A., and Weber M.J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17 (1997) 1595-1606
32. Ning Z.Q., Li J., McGuinness M., and Arceci R.J. STAT3 activation is required for Asp(816) mutant c-Kit induced tumorigenicity. Oncogene 20 (2001) 4528-4536
33. Lin P.Y., Liu H.J., Liao M.J., Yu F.L., Hsu H.Y., Lee J.W., and Shih W.L. Avian reovirus activates a novel proapoptotic signal by linking Src to p53. Apoptosis 11 (2006) 2179-2193
34. Yeh C.J., Lin P.Y., Liao M.H., Liu H.J., Lee J.W., Chiu S.J., Hsu H.Y., and Shih W.L. TNF-alpha mediates pseudorabies virus-induced apoptosis via the activation of p38 MAPK and JNK/SAPK signaling. Virology 38 (2008) 55-66
35. Lin P.Y., Lee J.W., Liao M.H., Hsu H.Y., Chiu S.J., Liu H.J., and Shih W.L. Modulation of p53 by mitogen-activated protein kinase pathways and protein kinase C delta during avian reovirus S1133-induced apoptosis. Virology 385 (2009) 323-334
36. Chou C.C., Sun Y.J., Meng M., and Hsiao C.D. The crystal structure of phosphoglucose isomerase/autocrine motility factor/neuroleukin complexed with its carbohydrate phosphate inhibitors suggests its substrate/receptor recognition. J. Biol. Chem. 275 (2000) 23154-23160
37. Lin H.Y., Kao Y.H., Chen S.T., and Meng M. Effects of inherited mutations on catalytic activity and structural stability of human glucose-6-phosphate isomerase expressed in Escherichia coli. Biochim. Biophys. Acta. 1794 (2009) 15-323
38. Havasi A., Li Z., Wang Z., Martin J.L., Botla V., Ruchalski K., chwartz J.H., and Borkan S.C. Hsp27 inhibits Bax activation and apoptosis via a phosphatidylinositol 3-kinase-dependent mechanism. J. Biol. Chem. 283 (2008) 12305-12313
39. Inoue T., Suzuki Y., Yoshimaru T., and Ra C. Nitric oxide protects mast cells from activation-induced cell death: the role of the phosphatidylinositol-3 kinase-Akt-endothelial nitric oxide synthase pathway. J. Leukoc. Biol. 83 (2008) 1218-1229
40. Ruano Y., Mollejo M., Camacho F.I., Rodriguez de Lope A., Fiano C., Ribalta T., Martinez P., Hernandez-Moneo J.L., and Melendez B. Identification of survival-related genes of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma multiforme. Cancer 112 (2008) 1575-1584
41. Vasconsuelo A., Milanesi L., and Boland R. 17 Beta-estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: role of the phosphatidylinositol 3-kinase/Akt pathway. J. Endocrinol. 196 (2008) 385-397
42. Hashimoto O., Ueno T., Kimura R., Ohtsubo M., Nakamura T., Koga H., Torimura T., Uchida S., Yamashita K., and Sata M. Inhibition of proteasome-dependent degradation of Wee1 in G2-arrested Hep3B cells by TGF beta 1. Mol. Carcinog. 36 (2003) 171-182
43. Vadrot N., Legrand A., Nello E., Bringuier A.F., Guillot R., and Feldmann G. Inducible nitric oxide synthase (iNOS) activity could be responsible for resistance or sensitivity to IFN-gamma-induced apoptosis in several human hepatoma cell lines. J. Interferon. Cytokine Res. 26 (2006) 901-913
44. Heldin C.H., Landstrom M., and Moustakas A. Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr. Opin. Cell. Biol. 21 (2009) 166-176
45. Dennler S., Itoh S., Vivien D., ten Dijke P., Huet S., and Gauthier J.M. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17 (1998) 3091-3100
46. Hua X., Miller Z.A., Wu G., Shi Y., and Lodish H.F. Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and Smad proteins. Proc. Natl. Acad. Sci. USA 96 (1999) 13130-13135
47. Mebratu Y., and Tesfaigzi Y. How ERK1/2 activation controls cell proliferation and cell death is subcellular localization the answer?. Cell Cycle 8 (2009) 1-8
48. Ahmed N.N., Grimes H.L., Bellacosa A., Chan T.O., and Tsichlis P.N. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc. Natl. Acad. Sci. USA 94 (1997) 3627-3632
49. Dudek H., Datta S.R., Franke T.F., Birnbaum M.J., Yao R., Cooper G.M., Segal R.A., Kaplan D.R., and Greenberg M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275 (1997) 661-665
50. Ammar H., and Closset J.L. Clusterin activates survival through the phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 283 (2008) 12851-12861
51. Belkhiri A., Dar A.A., Zaika A., Kelley M., and El-Rifai W. t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism. Cancer Res. 68 (2008) 395-403
52. Hu J.P., Nishishita K., Sakai E., Yoshida H., Kato Y., Tsukuba T., and Okamoto K. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways. Eur. J. Pharmacol. 580 (2008) 70-79
53. Chen R.H., Su Y.H., Chuang R.L., and Chang T.Y. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway. Oncogene 17 (1998) 1959-1968
54. Kohn A.D., Kovacina K.S., and Roth R.A. Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J. 14 (1995) 4288-4295
55. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., and Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231-241
56. Chung J., Kuo C.J., Crabtree G.R., and Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 69 (1992) 1227-1236
57. Lee S.O., Lou W., Johnson C.S., Trump D.L., and Gao A.C. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the STAT3 pathway. Prostate 60 (2004) 178-186
58. Sekikawa A., Fukui H., Fujii S., Ichikawa K., Tomita S., Imura J., Chiba T., and Fujimori T. REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells. Carcinogenesis 29 (2008) 76-83
59. Darnell J.E., Kerr Jr. I.M., and Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264 (1994) 1415-1421
60. Ihle J.N., and Kerr I.M. Jaks and stats in signaling by the cytokine receptor superfamily. Trends Genet. 11 (1995) 69-74